BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 14313750)

  • 1. EVIDENCE OF A NORMALLY FUNCTIONING PITUITARY TSH SECRETION MECHANISM IN A PATIENT WITH A HIGH BLOOD LEVEL OF LONG-ACTING THYROID STIMULATOR.
    ADAMS DD; KENNEDY TH
    J Clin Endocrinol Metab; 1965 May; 25():571-6. PubMed ID: 14313750
    [No Abstract]   [Full Text] [Related]  

  • 2. THYROTROPIN AND LONG-ACTING THYROID STIMULATOR ASSAYS IN THYROID DISEASE.
    PINCHERA A; PINCHERA MG; STANBURY JB
    J Clin Endocrinol Metab; 1965 Feb; 25():189-208. PubMed ID: 14264241
    [No Abstract]   [Full Text] [Related]  

  • 3. IMMUNOLOGICAL STUDIES ON THE LONG-ACTING THYROID STIMULATOR.
    DORRINGTON KJ; MUNRO DS
    Clin Sci; 1965 Feb; 28():165-74. PubMed ID: 14256898
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of iodine administration on the thyrotropic hormone and long-acting thyroid stimulator level in the plasma].
    Földes J; Krasznai I; Piroska E; Gesztesi E; Takács I
    Endokrinologie; 1967; 52(1):80-7. PubMed ID: 4171706
    [No Abstract]   [Full Text] [Related]  

  • 5. The nature and significance of the long-acting thyroid stimulator.
    Kriss J
    Adv Metab Disord; 1968; 3():209-30. PubMed ID: 4178338
    [No Abstract]   [Full Text] [Related]  

  • 6. PRESENCE OF THE LONG-ACTING THYROID STIMULATOR IN SERUM IN MONGOLISM WITHOUT HYPERTHYROIDISM.
    MOSIER HD
    J Clin Endocrinol Metab; 1965 Aug; 25():1005-8. PubMed ID: 14328369
    [No Abstract]   [Full Text] [Related]  

  • 7. THE EFFECT OF THYROID HORMONE ON THE LEVELS OF THYROTROPIN (TSH) AND LONG-ACTING THYROID STIMULATOR (L.A.T.S.) IN THYROID DISORDERS.
    SAKAGAMI A; FUKUCHI M; MASUI H; MIYAI K; IWATSUBO H; KUMAHARA Y; YOSHIDA T
    Med J Osaka Univ; 1964 Mar; 14():235-44. PubMed ID: 14195720
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the treatment of hyperthyroidism with Iodine-131.
    Torizuka K; Mori T; Konishi J; Morita R; Hamamoto K; Kusakabe T; Miyake T; Fukase M
    J Nucl Med; 1967 May; 8(5):335. PubMed ID: 6032620
    [No Abstract]   [Full Text] [Related]  

  • 9. ISOLATION AND IDENTIFICATION OF THE LONG-ACTING THYROID STIMULATOR AND ITS RELATION TO HYPERTHYROIDISM AND CIRCUMSCRIBED PRETIBIAL MYXEDEMA.
    KRISS JP; PLESHAKOV V; CHIEN JR
    J Clin Endocrinol Metab; 1964 Oct; 24():1005-28. PubMed ID: 14228525
    [No Abstract]   [Full Text] [Related]  

  • 10. [EFFECT OF THE ADMINISTRATION OF THE THYROID HORMONE ON THE LEVELS OF TSH AND LATS IN THE SERUM OF THE THYROID PATIENTS].
    SAKAGAMI A
    Nihon Naika Gakkai Zasshi; 1964 Feb; 52():1317-22. PubMed ID: 14156206
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical significance of LATS and TSH in the blood.
    Lemarchand-Béraud T; Griessen M; Scazziga BR
    Ann Clin Res; 1972 Jun; 4(3):121-37. PubMed ID: 4625026
    [No Abstract]   [Full Text] [Related]  

  • 12. Positive correlation of the long-acting thyroid stimulator (LATS) with the percentage of endogenously labelled 131 I triiodothyronine in the plasma of hyperthyroid patients.
    Emrich D; Albani M; zur Mühlen A von
    Acta Endocrinol (Copenh); 1971 Nov; 68(3):445-50. PubMed ID: 4107957
    [No Abstract]   [Full Text] [Related]  

  • 13. Thyroid suppression and the long-acting thyroid stimulator following radioactive iodine therapy for thyrotoxicosis.
    Alford FP; Larkins RG; Martin FI
    Aust N Z J Med; 1971 Nov; 1(4):339-45. PubMed ID: 5292990
    [No Abstract]   [Full Text] [Related]  

  • 14. The interaction between thyroid tissue and the long-acting thyroid stimulator.
    Kendall-Taylor P; Smith BR; Munro DS
    Q J Med; 1971 Oct; 40(160):564-5. PubMed ID: 4110160
    [No Abstract]   [Full Text] [Related]  

  • 15. [TSH and the "long-acting thyroid stimulator" (LATS) in patients with compensated hyperthyroidism].
    zur Mühlen A von ; Hesch RD; von Lilienfeld H; Emrich D
    Acta Endocrinol Suppl (Copenh); 1971; 152():86. PubMed ID: 5313711
    [No Abstract]   [Full Text] [Related]  

  • 16. Occurrence in thyrotoxicosis of a gamma globulin which protects LATS from neutralization by an extract of thyroid gland.
    Adams DD; Kennedy TH
    J Clin Endocrinol Metab; 1967 Feb; 27(2):173-7. PubMed ID: 4163610
    [No Abstract]   [Full Text] [Related]  

  • 17. CLINICAL STUDIES ON THE LONG-ACTING THYROID STIMULATOR.
    NOGUCHI A; KURIHARA H; SATO S
    J Clin Endocrinol Metab; 1964 Feb; 24():160-5. PubMed ID: 14123839
    [No Abstract]   [Full Text] [Related]  

  • 18. THE METABOLISM OF BIOLOGICALLY IMPORTANT RADIONUCLIDES. V. THE METABOLISM OF RADIOIODINE AND RADIATION DOSAGE IN MAN.
    HALNAN KE
    Br J Radiol; 1964 Feb; 37():101-7. PubMed ID: 14120786
    [No Abstract]   [Full Text] [Related]  

  • 19. [SUPPLEMENTARY ISOTOPE TESTS WITH RADIOACTIVE IODINE (I-131) IN THE DIAGNOSIS AND THERAPY OF THYROID DISEASES].
    GASIOROWSKI W
    Pol Tyg Lek; 1963 Aug; 18():1209-14. PubMed ID: 14087952
    [No Abstract]   [Full Text] [Related]  

  • 20. CLINICAL AND RADIOBIOLOGICAL OBSERVATIONS ON LATENT EFFCTS OF X-IRRADIATION ON THE THYROID GLAND.
    GREIG WR; BOYLE JA; BUCHANAN WW; FULTON S
    J Clin Endocrinol Metab; 1965 Aug; 25():1009-14. PubMed ID: 14328370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.